In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host disease.
Stoppa
A M
AM
Marrow Transplant Unit, Institut Paoli-Calmettes, Marseille, France.
Fossat
C
C
Sainty
D
D
Blaise
D
D
Viens
P
P
Baume
D
D
Bayssas
M
M
Juhan Vague
I
I
Maraninchi
D
D
D000328:Adult; D016026:Bone Marrow Transplantation; D002448:Cell Adhesion / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009504:Neutrophils / Q000187:drug effects*; D009580:Nitroblue Tetrazolium / Q000032:analysis; D010587:Phagocytosis / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D009580:Nitroblue Tetrazolium